All treatments were administered at study centers by trained investigators
However, because Wegovy reduces appetite and slows gastric emptying, some people may inadvertently eat less frequently or skip meals, which could potentially trigger hypoglycaemia in susceptible individuals
Wegovy is typically recommended along with lifestyle changes like a reduced-calorie diet and increased physical activity
[1] [3] Wegovy (semaglutide 2.4 mg), Zepbound (tirzepatide), and Saxenda (liraglutide 3 mg) are FDA-approved for weight management, while Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes management
Increasing the dose on your own, or more frequently than prescribed, raises the risk of severe gastrointestinal side effects and does not accelerate your long-term results
When using Semaglutide GLP-1 for weight loss, individuals can expect gradual and consistent reductions in body weight, especially when combined with healthy lifestyle changes like diet and exercise
